OpGen Inc. (OPGN)
4.00
-0.20 (-4.76%)
At close: Apr 04, 2025, 3:58 PM
-4.76% (1D)
| Bid | 3.9 |
| Market Cap | 40.27M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -15.53 |
| PE Ratio (ttm) | -0.26 |
| Forward PE | -3.69 |
| Analyst | n/a |
| Ask | 4 |
| Volume | 8,969 |
| Avg. Volume (20D) | 6,585 |
| Open | 4.00 |
| Previous Close | 4.20 |
| Day's Range | 3.50 - 4.19 |
| 52-Week Range | 0.53 - 8.40 |
| Beta | -1.61 |
About OPGN
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date May 5, 2015
Employees 85
Stock Exchange OTC
Ticker Symbol OPGN
Website https://www.opgen.com
